Clinical trials
Terminated Phase 1/2 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 8 |
| 2016 | 2 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 14 |
| Fred Hutchinson Cancer Center | 5 |
| Bellicum Pharmaceuticals | 3 |
| Incyte Corporation | 3 |
| Novartis Pharmaceuticals | 3 |
| Washington University School of Medicine | 3 |
| Abramson Cancer Center at Penn Medicine | 2 |
| City of Hope Medical Center | 2 |
| Hoffmann-La Roche | 2 |
| National Cancer Institute (NCI) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 91 |
| Myelodysplastic Syndromes | 28 |
| Leukemia | 24 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 17 |
| Recurrence | 11 |
| Hematologic Neoplasms | 6 |
| Multiple Myeloma | 6 |
| Blast Crisis | 5 |
| Congenital Abnormalities | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.